Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.